Full Text of HR0450 97th General Assembly
HR0450 97TH GENERAL ASSEMBLY |
| | HR0450 | | LRB097 12219 RPM 56653 r |
|
| 1 | | HOUSE RESOLUTION
| 2 | | WHEREAS, In response to increasing prescription drug | 3 | | costs, many health plans and prescription drug plans have | 4 | | increased enrollee cost-sharing amounts, instituted | 5 | | coinsurance, and created specialty tiers resulting in | 6 | | increased medication costs for patients participating in those | 7 | | plans; and
| 8 | | WHEREAS, The National Conference of State Legislatures | 9 | | reports that between the years 2000 and 2009, copayments for | 10 | | insured workers have increased for specialty-tier drugs; and
| 11 | | WHEREAS, Many health plans and prescription drug plans now | 12 | | require individuals to pay a coinsurance or percentage of the | 13 | | cost of fourth-tier or specialty-tier prescription | 14 | | medications; and | 15 | | WHEREAS, Fourth-tier or specialty-tier medications often | 16 | | include medications for chronic diseases, including certain | 17 | | types of cancer, hemophilia, multiple sclerosis, myositis, | 18 | | neuropathy, arthritis, human immunodeficiency virus, and other | 19 | | diseases and disorders; and
| 20 | | WHEREAS, Coinsurance, cost-sharing, and specialty-tier | 21 | | pricing place significant and onerous financial burdens upon |
| | | HR0450 | - 2 - | LRB097 12219 RPM 56653 r |
|
| 1 | | insured individuals with chronic health care issues requiring | 2 | | prescription medication, in many cases leading to decreased | 3 | | adherence or failure to take medications as prescribed, | 4 | | resulting in acute incidents and negative health outcomes; | 5 | | therefore, be it
| 6 | | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE | 7 | | NINETY-SEVENTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that | 8 | | the Department of Insurance is requested to study the impacts | 9 | | of cost sharing, coinsurance, and specialty-tier pricing for | 10 | | prescription medications; and be it further
| 11 | | RESOLVED, That the study shall (1) determine the impact of | 12 | | cost sharing, coinsurance, and specialty-tier pricing on | 13 | | access to prescription medications for chronic health | 14 | | disorders and (2) identify and evaluate options for reducing | 15 | | any negative impacts of cost sharing, coinsurance, and | 16 | | specialty-tier pricing, including, but not limited to, | 17 | | statutory limitations on cost sharing obligations for | 18 | | prescription medications; and be it further | 19 | | RESOLVED, That the Department of Insurance shall report to | 20 | | the General Assembly on the first day of the regular session, | 21 | | 2012, on its findings, conclusions, and recommendations | 22 | | together with drafts of legislation necessary to effectuate its | 23 | | recommendations; and be it further
|
| | | HR0450 | - 3 - | LRB097 12219 RPM 56653 r |
|
| 1 | | RESOLVED, That a suitable copy of this resolution be | 2 | | presented to the Director of Insurance.
|
|